These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


754 related items for PubMed ID: 26311551

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The value of MCV, MCH and HbA(2) in laboratory screening of thalassemia].
    Li LY, Li Q, Song LL, Jin WJ, Ma ZH, Yu YH, Zhong M.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):96-100. PubMed ID: 22455739
    [Abstract] [Full Text] [Related]

  • 3. [A study on gene mutation spectrums of α- and β-thalassemias in populations of Yunnan Province and the prenatal gene diagnosis].
    Zhu BS, He J, Zhang J, Zeng XH, Su J, Xu XH, Li SY, Chen H, Zhang YH.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):85-9. PubMed ID: 22455737
    [Abstract] [Full Text] [Related]

  • 4. Efficiency of premarital screening of beta-thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran.
    Karimi M, Rasekhi AR.
    Haematologia (Budap); 2002 Feb; 32(2):129-33. PubMed ID: 12412732
    [Abstract] [Full Text] [Related]

  • 5. Effective screening for double heterozygosity of Hb E/alpha0-thalassemia.
    Sanchaisuriya K, Chirakul S, Srivorakun H, Fucharoen G, Fucharoen S, Changtrakul Y, Sanchaisuriya P.
    Ann Hematol; 2008 Nov; 87(11):911-4. PubMed ID: 18575861
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity and specificity of mean corpuscular hemoglobin (MCH): for screening alpha-thalassemia-1 trait and beta-thalassemia trait.
    Pranpanus S, Sirichotiyakul S, Srisupundit K, Tongsong T.
    J Med Assoc Thai; 2009 Jun; 92(6):739-43. PubMed ID: 19530577
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the validity of Hb A2 and mean corpuscular haemoglobin action values in antenatal screening for beta thalassaemia carriers in England.
    Daniel Y, Cartwright R, Rennie K, Streetly A, Howard J.
    Br J Haematol; 2014 Aug; 166(4):607-11. PubMed ID: 24754789
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effectiveness of Using Mean Corpuscular Volume and Mean Corpuscular Hemoglobin for Beta-thalassemia Carrier Screening in the Guangdong Population of China.
    Gu H, Wang YX, Du MX, Xu SS, Zhou BY, Li MZ.
    Biomed Environ Sci; 2021 Aug 20; 34(8):667-671. PubMed ID: 34474730
    [Abstract] [Full Text] [Related]

  • 10. Can Couples With MCV≥80, MCH<26, HbA2<3.2, HbF<3 be Classified as Low-risk β-Thalassemia Group?
    Mirzakhani M, Tarrahi MJ, Baghersad A, Maracy MR.
    J Pediatr Hematol Oncol; 2019 May 20; 41(4):303-306. PubMed ID: 30676434
    [Abstract] [Full Text] [Related]

  • 11. Co-inheritance of alpha-and beta-thalassemia in Khuzestan Province, Iran.
    Rahim F, Kaikhaei B, Zandian K, Hoseini A.
    Hematology; 2008 Feb 20; 13(1):59-64. PubMed ID: 18534068
    [Abstract] [Full Text] [Related]

  • 12. [Large-scale population-based genetic screening and prenatal diagnosis for thalassemias in Zhuhai City of Guangdong Province].
    Zhou YQ, Shang X, Yin BM, Xiong F, Xiao QZ, Zhou WJ, Zhang YL, Xu XM.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb 20; 47(2):90-5. PubMed ID: 22455738
    [Abstract] [Full Text] [Related]

  • 13. Proposed screening criteria for beta-thalassemia trait during early pregnancy in southern China.
    Liao C, Xie XM, Zhong HZ, Zhou JY, Li DZ.
    Hemoglobin; 2009 Feb 20; 33(6):528-33. PubMed ID: 19958202
    [Abstract] [Full Text] [Related]

  • 14. Effects of α-thalassaemia mutations on the haematological parameters of β-thalassaemia carriers.
    Saleh-Gohari N, Khademi Bami M, Nikbakht R, Karimi-Maleh H.
    J Clin Pathol; 2015 Jul 20; 68(7):562-6. PubMed ID: 25935548
    [Abstract] [Full Text] [Related]

  • 15. Sensitivity and specificity of mean corpuscular volume testing for screening for alpha-thalassemia-1 and beta-thalassemia traits.
    Sirichotiyakul S, Maneerat J, Sa-nguansermsri T, Dhananjayanonda P, Tongsong T.
    J Obstet Gynaecol Res; 2005 Jun 20; 31(3):198-201. PubMed ID: 15916654
    [Abstract] [Full Text] [Related]

  • 16. [Diagnostic Cut-Off Value of RDW for Screening Thalassemia and the Combined Determination of MCV, MCH, HBA 2 and RDW].
    Song QL, Guo YL, He YJ, He C, Zhang T, Cai Y, Liu W, Zhu XC, Liu QS.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun 20; 29(3):847-852. PubMed ID: 34105482
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Erythrocyte indices in a large cohort of β-thalassemia carrier: Implication for population screening in an area with high prevalence and heterogeneity of thalassemia.
    Singha K, Taweenan W, Fucharoen G, Fucharoen S.
    Int J Lab Hematol; 2019 Aug 20; 41(4):513-518. PubMed ID: 31099487
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Krüppel-Like Factor 1 Gene Mutations in Thalassemia Patients from North Iran: Report of a New Mutation Associated with β-Thalassemia Intermedia.
    Tamaddoni A, Khabaz Astaneh S, Tabaripour R, Akhavan-Niaki H.
    Hemoglobin; 2019 Jan 20; 43(1):12-17. PubMed ID: 30747024
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.